Immunostimulatory compositions and uses thereof

Details Immunostimulatory compositions and uses thereof Immunostimulatory compositions and uses thereof

2005-02-04

2011-10-11

Saoud, Christine J (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S021500, C530S324000, C530S325000, C530S326000, C530S327000, C435S069100

Reexamination Certificate

active

08034773

ABSTRACT:
The present invention provides novel immuno-stimulatory polypeptides, and methods for their use and identification.

REFERENCES:
patent: 5641747 (1997-06-01), Popoff et al.
patent: 5677276 (1997-10-01), Dickerson et al.
patent: 5753481 (1998-05-01), Niwa et al.
patent: 5910310 (1999-06-01), Heinen et al.
patent: 5919998 (1999-07-01), Bandurski et al.
patent: 6159937 (2000-12-01), Larsen et al.
patent: 6193981 (2001-02-01), Goldstein
patent: 6498020 (2002-12-01), Walker et al.
patent: 6551795 (2003-04-01), Rubenfield et al.
patent: 7105481 (2006-09-01), Uutela et al.
patent: 2003/0073637 (2003-04-01), Uutela et al.
patent: 2004/0031072 (2004-02-01), La Rosa et al.
patent: 2004/0123343 (2004-06-01), La Rosa et al.
patent: 2004/0248192 (2004-12-01), Marchalonis et al.
patent: 2005/0063937 (2005-03-01), Li et al.
patent: 2006/0024668 (2006-02-01), Hock
patent: 2006/0078535 (2006-04-01), Livant
patent: 2006/0148093 (2006-07-01), Gygi et al.
patent: 2006/0160730 (2006-07-01), Cuttitta et al.
patent: 2006/0189538 (2006-08-01), Secombes et al.
patent: 2006/0269519 (2006-11-01), Chen et al.
patent: 2006/0287234 (2006-12-01), Breen et al.
patent: 2007/0003542 (2007-01-01), Zimmerman et al.
patent: 2007/0021342 (2007-01-01), Breen et al.
patent: 2007/0149475 (2007-06-01), Murray et al.
patent: 2007/0154448 (2007-07-01), Reid et al.
patent: 2008/0102076 (2008-05-01), Eggink et al.
patent: 2009/0041793 (2009-02-01), Eggink et al.
patent: 2290722 (2001-06-01), None
patent: WO-96/40903 (1996-12-01), None
patent: WO-00/31130 (2000-06-01), None
patent: WO-02/058589 (2002-08-01), None
patent: 03/091275 (2003-11-01), None
patent: 04/011650 (2004-02-01), None
patent: 05/087793 (2005-09-01), None
patent: 06/063028 (2006-06-01), None
patent: 2006/105021 (2006-10-01), None
European Search Report for European patent application No. 07869233.2 dated May 11, 2010.
GlaxoSmithKline, (2005a) Study of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 in R5-Tropic Treatment-Experienced HIV Infected Subjects, ClinicalTrials.gov (Sep. 13, 2005) Identifier: NCT00197145S, (Terminated in 2005).
GlaxoSmithKline, (2005b) “GlaxoSmithKline Halts Trials of Experimental CCR5 Inhibitor Aplaviroc in Treatnnentnaïve HIV Patients Due to Concerns about Liver Toxicity,” Statement of HIV Patient Community: Information from GlaxoSmithKline on Changes to Studies Investigational CCR5 Entry Inhibitor Aplaviroc (GW873140) (Sep. 15, 2005), pp. 1-2.
International Search Report for WO/2006/063028 dated Nov. 16, 2006 (6 sheets).
International Search Report for WO/2005/087793 dated Apr. 5, 2006 (6 sheets).
PCT/US2007/087413 International Search Report dated Jul. 29, 2008.
PCT/US2007/087425 International Search Report dated Aug. 5, 2008.
Supplementary European Search Report for European application No. 07871699.0 dated May 17, 2010 (8 sheets).
Written Opinion of the International Searching Authority for WO/2005/087793 dated Apr. 5, 2006 (7 sheets).
Written Opinion of the International Searching Authority for WO/2006/063028 dated Nov. 16, 2006 (9 sheets).
Written Opinion of the International Searching Authority for WO/2008/076815 dated Jul. 29, 2008 (6 sheets).
Written Opinion of the International Searching Authority for WO/2008/076824 dated Aug. 5, 2008 (6 sheets).
Chargelegue et al., “A Peptide Mimic of a Protective Epitope of Respiratory Syncytial Virus Selected from a Combinatorial Library Induces Virus-Neutralizing Antibodies and Reduces Viral Load in Vivo”, Journal of Virology, 72 (3):2040-2046 (Mar. 1998).
Chersi et al., “Specifications of rabbit antisera to multiple antigen (MAP) peptides”, ournal of Biosciences, 50 (9-10):735-738 (Sep. 1, 1995) Abstract Only.
Ciesielski et al., “Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat giloma model”, Cancer Immunol Immunother, 54:107-119 (2005).
Eggink et al., “A biologically active peptide mimetic of N-acetylgalactosamine/galactose”, BMC Research Notes, 2:23 (2009).
G.Fätkenheuer et al., “Efficacy of Short-Term Monotherapy with Maraviroc, a New CRC5 Antagonist, in Patients Infected with HIV 1,” Natire Med (2005), vol. 11, pp. 1170-1172.
J. Cohen, “Hope on New AIDS Drugs, but Breast-Feeding Strategy Backfires,” Science (2007), vol. 315, p. 1357.
J. Stover et al., “The Global Impact of Scaling up HIV/AIDS Prevention Programs in Low-and Middle-Income Countries,” Science (2006) vol. 311, pp. 1474-1476.
Manki et al., “Vaccination with Multiple Antigen Peptide as Rejection Antigen Peptide in Murine Leukemia”, Cancer Research, 58:1960-1964 (May 1, 1998).
Nicolaus, “Symbiotic Approach to Drug Design”, Decision Making in Drug Research, pp. 173-186 (Jan. 1, 1983).
Olszewska et al., “Protection against Measles Virus-Induced Encephalitis by Anti-mimotope Antibodies: The Rose of Antibody Affinity” Virology, 272(1):98-105 (Jun. 20, 2000).
P.W. Latham, “Therapeutic Peptides Revisited,” Nature Biotech (1999), vol. 17, pp. 755-757.
Sarig et al., “Telomeric and Tetraplex DNA Binding Properties of qTBP42: A Homologue of the CArG Box Binding Protein CBF-A”; Biochemical and Biophysical Research Communications 1997, vol. 237, No. 3, pp. 617-623.

Affiliated with

Also associated with

Rating

Immunostimulatory compositions and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunostimulatory compositions and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunostimulatory compositions and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4267783